Ankur Kapoor is a partner at Constantine Cannon and has been at the firm since 2004, focusing on antitrust litigation and counseling. Ankur is an active member of the American Bar Association’s Section of Antitrust Law. He was an Editor of Antitrust Law Developments (7th ed. 2012) and currently serves as a Vice Chair of the Media and Technology Committee. Ankur is a graduate of the New York University School of Law, where he was a member of the National Moot Court Competition Team. He holds a B.A. from Columbia University, where he majored in Economics and minored in Computer Science. Ankur is admitted to practice in New York State, the United States District Courts for the Eastern and Southern Districts of New York, and the United States Court of Appeals for the Second Circuit.
243
A Nearsighted Approach to Product Market Definition : Court Rejects Low-Cost Rival’s Antitrust Claims Alleging Novartis Blocked Competition in the Sale of Eye-Disease Treatments* One antitrust case we have been watching closely is the patent-related antitrust suit filed by biotechnology (...)
427
Third Circuit Shows No Love For Lovenox® Bundling Theory*Citing the well-known maxim that the antitrust laws are concerned with “the protection of competition, not competitors,” the U.S. Court of Appeals for the Third Circuit on Wednesday affirmed summary judgment for Defendant Sanofi Aventis (...)
412
Regulators Prescribing Higher Dose Of Pharmaceutical Antitrust Enforcement* Antitrust enforcers returned to their offices after Labor Day, refreshed and ready to tackle what they view to be anticompetitive practices by pharmaceutical companies to delay entry of lower-priced generic drugs. (...)
